OMass Therapeutics

OMass Therapeutics is a biotechnology company developing small molecule therapeutics against membrane proteins, GPCRs, and intracellular complexes that have historically been difficult to drug.

Its proprietary platform combines native mass spectrometry, novel biochemistry, and custom chemistry to interrogate protein targets within their native molecular ecosystem.

The company's pipeline is focused on rare diseases and immunological conditions, including congenital adrenal hyperplasia, lupus, and inflammatory bowel disease.